Regional liver therapy using oncolytic virus to target hepatic colorectal metastases.
about
Oncolytic virotherapy as emerging immunotherapeutic modality: potential of parvovirus h-1Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity.Adaptive T cell responses induced by oncolytic Herpes Simplex Virus-granulocyte macrophage-colony-stimulating factor therapy expanded by dendritic cell and cytokine-induced killer cell adoptive therapy.Chimeric Antigen Receptors T Cell Therapy in Solid Tumor: Challenges and Clinical Applications.Preclinical safety evaluation of hepatic arterial infusion of oncolytic poxvirus
P2860
Regional liver therapy using oncolytic virus to target hepatic colorectal metastases.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Regional liver therapy using oncolytic virus to target hepatic colorectal metastases.
@en
Regional liver therapy using oncolytic virus to target hepatic colorectal metastases.
@nl
type
label
Regional liver therapy using oncolytic virus to target hepatic colorectal metastases.
@en
Regional liver therapy using oncolytic virus to target hepatic colorectal metastases.
@nl
prefLabel
Regional liver therapy using oncolytic virus to target hepatic colorectal metastases.
@en
Regional liver therapy using oncolytic virus to target hepatic colorectal metastases.
@nl
P2860
P1433
P1476
Regional liver therapy using oncolytic virus to target hepatic colorectal metastases.
@en
P2093
Joshua Carson
Susanne G Carpenter
P2860
P304
P356
10.1053/J.SEMINONCOL.2010.03.001
P50
P577
2010-04-01T00:00:00Z